Oruka Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.52	46.94	61.58	37.43	42.45	53.36
Short-Term Investments	339.31	290.11	314.07	-	-	-
Cash & Short-Term Investments	388.83	337.04	375.65	37.43	42.45	53.36
Cash Growth	11.38%	-10.28%	903.58%	-11.81%	-20.45%	8.74%
Other Current Assets	6.42	6.81	1.22	0.16	0.25	1.06
Total Current Assets	395.25	343.86	376.87	37.59	42.7	54.42
Net Property, Plant & Equipment	2.01	2.12	1.04	0.26	0.37	0.49
Long-Term Investments	107.12	142.54	18.07	-	-	-
Other Long-Term Assets	0.1	0.1	0.04	0.01	0.02	0.02
Total Assets	504.48	488.62	396.02	37.86	43.09	54.92
Accounts Payable	3.66	4.16	3.46	0.36	0.33	1.12
Accrued Expenses	9.29	10.59	3.35	0.28	0.17	2.38
Current Portion of Leases	0.68	0.62	0.21	-	-	-
Other Current Liabilities	3	0.01	6.02	-	0.63	-
Total Current Liabilities	16.63	15.37	13.04	0.64	1.13	3.5
Long-Term Leases	1.13	1.31	0.76	0.2	0.28	0.38
Total Long-Term Liabilities	1.13	1.31	0.76	0.2	0.28	0.38
Total Liabilities	17.76	16.69	13.8	0.84	1.41	3.88
Preferred Stock	2.93	2.93	2.93	-	-	-
Common Stock	0.05	0.05	0.04	0.01	0.01	0.01
Additional Paid-in Capital	705.2	657.56	463.02	225.75	225.06	224.51
Accumulated Other Comprehensive Income	-0.48	0.55	-0.04	-	-	-
Retained Earnings	-220.98	-189.16	-83.72	-188.74	-183.4	-173.48
Shareholders' Equity	486.72	471.93	382.22	37.02	41.67	51.04
Total Liabilities & Equity	504.48	488.62	396.02	37.86	43.09	54.92
Total Debt	1.81	1.93	0.97	0.2	0.28	0.38
Net Cash (Debt)	387.02	335.11	374.68	37.23	42.17	52.98
Net Cash Growth	15.49%	-10.56%	906.47%	-11.71%	-20.41%	8.87%
Net Cash Per Share	7.90	7.35	22.32	30.99	35.11	45.72
Book Value	486.72	471.93	382.22	37.02	41.67	51.04
Book Value Per Share	9.94	10.35	22.77	30.82	34.70	44.05
Tangible Book Value	486.72	471.93	382.22	37.02	41.67	51.04
Tangible Book Value Per Share	9.94	10.35	22.77	30.82	34.70	44.05

SEC Filings: 10-K · 10-Q